At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 8 enrolled
Drug / intervention
Crisaboroledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
In Brief
A Phase 2 clinical trial evaluating Crisaborole for Morphea. Completed, enrolled 8 participants across 1 site.
Detailed Summary
This is a pilot study to determine the safety and clinical efficacy of crisaborole 2% ointment in the treatment of morphea.
Study Details
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartSep 2018
Primary CompletionMar 2020
TodayJul 2026
First PostedNov 22, 2017
Enrollment StartSep 1, 2018
Primary CompletionMar 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.6 years ago
Interventions
Crisaboroledrug
Apply Crisaborole 2% ointment to affected skin twice per day.